Unique ID issued by UMIN | UMIN000016948 |
---|---|
Receipt number | R000019674 |
Scientific Title | Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy |
Date of disclosure of the study information | 2015/04/01 |
Last modified on | 2017/03/21 21:09:21 |
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy
The effect of Integrated Approach to Symptom Management for oral mucositis under hematologic cancer therapy
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy
The effect of Integrated Approach to Symptom Management for oral mucositis under hematologic cancer therapy
Japan |
hematological malignancies
oral mucositis associated with cancer therapy
Nursing |
Malignancy
NO
To examine the effect of the Integrated Approach to Symptom Management (IASM) for the patients who has oral mucositis associated with hematologic cancer therapy. The guide book ver.9 for nurse's activity will be used.
Efficacy
condition of oral hygiene include oral mucositis, mouth moist
self-efficacy scale for cancer patients
SF-36v2
self-care ability (scale)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Behavior,custom |
Period: to March 31st 2016
Frequency : 4 times
First Intervention:
1)Interview according to guide book. Conduct observation of oral condition.
2)Understand the symptom experience of the patient and feedback it empathically.
3)Assessment of self-care ability.
4)Share the plan of the preventive intervention.
5)Provide essential knowledge, essential skill, essential nursing support. (use the original pamphlet)
6)Measure the outcome scales.
7)Patients will record their symptom and care for themselves.
Second and Third Intervention:
1)Listen and understand patient's symptom experience.
2)Positive feedback.
3)Practice the above 3)4)5)6).
Final Intervention:
1)Review and share the process for 4 weeks.
2)Recognize and identify patient's effort and make sure their achievement.
3)Measure the outcome scales.
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients undergoing hematologic cancer therapy
2)Patients who have the ability to communicate in Japanese and respond to the questionnaire without any cognitive disability.
1)Patients undergoing myeloablative regimens for hematopoietic stem cell transplantation.
20
1st name | |
Middle name | |
Last name | Atsuko Uchinuno |
University of Hyogo
College of Nursing
13-71 Kitaouji-cho,Akashi,Hyogo,673-8588 JAPAN
078-925-9435
a_uchinuno@cnas.u-hyogo.ac.jp
1st name | |
Middle name | |
Last name | Hiroe Nakano |
University of Hyogo
College of Nursing
13-71 Kitaouji-cho,Akashi,Hyogo,673-8588 JAPAN
078-925-9434
http://sm-support.net/
hiroe_nakano@cnas.u-hyogo.ac.jp
University of Hyogo
Japan Society for the promotion of Science
Japan
NO
京都大学医学部附属病院(京都府)、熊本医療センター(熊本県)、熊本大学医学部附属病院(熊本県)、浜の町病院(福岡県)
2015 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2015 | Year | 04 | Month | 01 | Day |
2015 | Year | 06 | Month | 01 | Day |
2015 | Year | 03 | Month | 27 | Day |
2017 | Year | 03 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019674